Overall survival was also longer with adjuvant PCV, but the difference did not reach statistical significance ( Figure 1 ).
← all excerpts
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors.
1
—
—
Overall survival was also longer with adjuvant PCV, but the difference did not reach statistical significance ( Figure 1 ).